Novartis recently announced the final overall survival (OS) analysis results of the phase III SOLAR-1 study of the new breast cancer drug Piqray (alpe···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 102
EU Approval Details of PiqrayNovartis recently announced that the European Commission (EC) has approved Piqray (alpelisib) in combination with fulvest···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 101
Cabozantinib is a broad-spectrum, multi-target anti-tumor drug developed by Exelixis Biopharmaceuticals, Inc. While most anti-tumor drugs target 1-3 t···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 120
On March 26, 2025, Exelixis announced that the U.S. Food and Drug Administration (FDA) has approved cabozantinib (Cabometyx) for the treatment of two ···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 96
Cabozantinib is a small-molecule, multi-target tyrosine kinase inhibitor developed by Exelixis in the United States. In November 2012, the FDA first a···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 125
Cabozantinib is a broad-spectrum anticancer drug targeting multiple targets, inhibiting at least nine targets including MET, VEGFR1/2/3, ROS1, RET, AX···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 106
Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus (CMV) infections, with widespread application particularly in pati···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 108
Valganciclovir (Valcyte) is a key antiviral drug for the treatment and prevention of cytomegalovirus (CMV) infections, especially indicated for CMV re···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 113
Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 111
Valcyte can harm your kidneys,especially if you also use certain medicines for infections, cancer,osteoporosis, organ transplant rejection, bowel diso···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 116
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection. Avoid activities that may increas···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 109
Precautions1. Do Not Substitute Valganciclovir for Ganciclovir Capsules on a 1:1 BasisThe absolute bioavailability of valganciclovir, measured as ganc···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 104
Contraindications1.Valganciclovir hydrochloride tablets are contraindicated in patients with known hypersensitivity to valganciclovir, ganciclovir, or···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 109
Dacomitinib is a targeted therapy for non‑small cell lung cancer (NSCLC) with EGFR mutations. In 2026, its prices show significant variations across g···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 106
Dacomitinib is a targeted therapy for non-small cell lung cancer with EGFR mutations. The channel of purchase directly affects medication safety and t···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 103
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



